Clinical Trial Update: Study of Apatinib in Patients With Differentiated Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of apatinib in differentiated thyroid cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer
• Thyroid Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED